Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ASCO 2026: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2026: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
1 Jun 2026

Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer

Dr Lucy Gilbert - McGill University Health Centre, Montreal, Canada
Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer ( Dr Lucy Gilbert - McGill University Health Centre, Montreal, Canada )
1 Jun 2026

Short-term fasting linked to improved chemo response in advanced ovarian cancer

Dr Claudia Marchetti - Policlinico Universitario Agostino Gemelli, Rome, Italy
Short-term fasting linked to improved chemo response in advanced ovarian cancer ( Dr Claudia Marchetti - Policlinico Universitario Agostino Gemelli, Rome, Italy )
1 Jun 2026

ASCO 2026: Latest in prostate cancer

Prof Eleni Efstathiou, Prof Boris Hadaschik, Dr Mary-Ellen Taplin and Prof Axel Merseburger
ASCO 2026: Latest in prostate cancer ( Prof Eleni Efstathiou, Prof Boris Hadaschik, Dr Mary-Ellen Taplin and Prof Axel Merseburger )
1 Jun 2026

Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission

Dr Robert Stein - University College London, London, UK
Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission ( Dr Robert Stein - University College London, London, UK )
1 Jun 2026

Tarlatamab in SCLC shows consistent effect and low immune toxicity across age groups

Dr Raymart Macasaet - Monmouth Medical Center, Long Branch, USA
Tarlatamab in SCLC shows consistent effect and low immune toxicity across age groups ( Dr Raymart Macasaet - Monmouth Medical Center, Long Branch, USA )
1 Jun 2026

Darovasertib plus crizotinib improves outcomes in HLA-A2–negative metastatic uveal melanoma

Dr Marlana Orloff - Thomas Jefferson University Hospital, Philadelphia, USA
Darovasertib plus crizotinib improves outcomes in HLA-A2–negative metastatic uveal melanoma ( Dr Marlana Orloff - Thomas Jefferson University Hospital, Philadelphia, USA )
1 Jun 2026

Tarlatamab improves brain metastases control and survival compared to chemo in SCLC

Dr Giannis Mountzios - The University of Athens, Athens, Greece
Tarlatamab improves brain metastases control and survival compared to chemo in SCLC ( Dr Giannis Mountzios - The University of Athens, Athens, Greece )
1 Jun 2026

ASCO 2026: Latest updates in mRCC

Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke
ASCO 2026: Latest updates in mRCC ( Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke )
30 May 2026

Combination therapeutic strategies for aRCC patients with bone metastases

Prof Stéphane Oudard and Dr Stefanie Zschäbitz
Combination therapeutic strategies for aRCC patients with bone metastases ( Prof Stéphane Oudard and Dr Stefanie Zschäbitz )
13 May 2026

ZL-1310 shows promising activity in DLL3-positive neuroendocrine carcinomas

Dr Rohit Thummalapalli - Memorial Sloan Kettering Cancer Center, New York, USA
ZL-1310 shows promising activity in DLL3-positive neuroendocrine carcinomas ( Dr Rohit Thummalapalli - Memorial Sloan Kettering Cancer Center, New York, USA )
27 Apr 2026

DLL3 expression in circulating tumour cells predicts response to tarlatamab in small cell lung cancer

Dr Avanish Mishra - Krantz Family Center for Cancer Research, Boston, USA
DLL3 expression in circulating tumour cells predicts response to tarlatamab in small cell lung cancer ( Dr Avanish Mishra - Krantz Family Center for Cancer Research, Boston, USA )
27 Apr 2026